Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,591 | 583 | 99.6% |
| Education | $58.43 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,474 | 45 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,088 | 28 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $879.15 | 38 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $874.20 | 33 | $0 (2024) |
| ABBVIE INC. | $861.03 | 35 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $852.76 | 28 | $0 (2024) |
| ITI, Inc. | $775.90 | 33 | $0 (2023) |
| Neos Therapeutics, LP | $751.10 | 60 | $0 (2024) |
| Bausch Health US, LLC | $482.12 | 32 | $0 (2024) |
| Axsome Therapeutics, Inc. | $475.51 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,380 | 149 | ABBVIE INC. ($750.73) |
| 2023 | $2,987 | 98 | Janssen Pharmaceuticals, Inc ($429.46) |
| 2022 | $1,522 | 74 | ITI, Inc. ($411.06) |
| 2021 | $1,378 | 94 | Janssen Pharmaceuticals, Inc ($213.57) |
| 2020 | $766.24 | 58 | Eisai Inc. ($149.02) |
| 2019 | $1,628 | 52 | Janssen Pharmaceuticals, Inc ($357.30) |
| 2018 | $449.87 | 25 | Shire North American Group Inc ($187.19) |
| 2017 | $539.09 | 38 | Neos Therapeutics, LP ($176.82) |
All Payment Transactions
588 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/12/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/11/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/03/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $122.02 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/12/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Neuroscience | ||||||
| 11/07/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $124.79 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $19.77 | General |
| 10/30/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: OUD | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $124.30 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 890 | 3,785 | $862,717 | $272,812 |
| 2022 | 11 | 609 | 1,663 | $434,337 | $130,428 |
| 2021 | 10 | 458 | 1,250 | $343,646 | $112,314 |
| 2020 | 8 | 298 | 882 | $242,875 | $66,415 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 79 | 801 | $200,250 | $72,078 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 220 | 626 | $193,890 | $55,770 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 75 | 413 | $172,221 | $53,783 | 31.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 18 | 1,083 | $81,458 | $26,165 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 335 | $70,350 | $19,976 | 28.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 164 | $27,060 | $9,860 | 36.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 71 | 71 | $24,850 | $9,696 | 39.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 58 | $28,884 | $7,515 | 26.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 59 | 98 | $16,119 | $5,151 | 32.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 57 | 57 | $21,888 | $4,949 | 22.6% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2023 | 23 | 27 | $7,755 | $3,060 | 39.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $9,000 | $2,488 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,692 | $1,633 | 24.4% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 23 | 23 | $2,300 | $690.17 | 30.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 92 | 530 | $132,500 | $41,179 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 355 | $110,192 | $31,925 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 368 | $77,255 | $21,990 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 81 | $33,777 | $10,572 | 31.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 136 | $22,440 | $7,248 | 32.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 42 | $20,916 | $6,120 | 29.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 35 | 35 | $11,340 | $4,936 | 43.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 35 | 36 | $13,824 | $2,889 | 20.9% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2022 | 12 | 14 | $4,020 | $1,677 | 41.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 32 | 49 | $6,125 | $1,404 | 22.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 17 | $1,948 | $487.85 | 25.0% |
About Dr. Rano Mathew, MD
Dr. Rano Mathew, MD is a Psychiatry healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972694297.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rano Mathew, MD has received a total of $13,650 in payments from pharmaceutical and medical device companies, with $4,380 received in 2024. These payments were reported across 588 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($13,591).
As a Medicare-enrolled provider, Mathew has provided services to 2,255 Medicare beneficiaries, totaling 7,580 services with total Medicare billing of $581,968. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Wilmington, NC
- Active Since 09/28/2006
- Last Updated 06/04/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1972694297
Products in Payments
- SPRAVATO (Drug) $1,268
- REXULTI (Drug) $1,151
- CAPLYTA (Drug) $1,106
- INGREZZA (Drug) $1,088
- VRAYLAR (Drug) $966.79
- Adzenys XR-ODT (Drug) $726.14
- Auvelity (Drug) $475.51
- HETLIOZ (Drug) $441.84
- FANAPT (Drug) $410.92
- Dayvigo (Drug) $407.28
- VYVANSE (Drug) $381.31
- Austedo XR (Drug) $357.55
- QUVIVIQ (Drug) $356.58
- Azstarys (Drug) $355.24
- AUSTEDO (Drug) $316.96
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $270.04
- APLENZIN (Drug) $237.20
- LATUDA (Drug) $230.00
- WELLBUTRIN (Drug) $225.98
- INVEGA SUSTENNA (Drug) $205.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Wilmington
Dr. Ranganathan Ram
Psychiatry — Payments: $362,123
Dr. Paul Buongiorno, M.d, M.D
Psychiatry — Payments: $262,847
Dr. Eric Christopher, M.d, M.D
Psychiatry — Payments: $89,218
Dr. Manisha Wadhwa, M.d, M.D
Psychiatry — Payments: $71,032
Sandeep Gupta, Md, MD
Psychiatry — Payments: $15,589
Dr. Brett Gurkin, M.d, M.D
Psychiatry — Payments: $9,247